Midodrine Tillomed (Midodrine Hydrochloride)

Midodrine, the active ingredient in Midodrine Tillomed, is an alpha‑1 adrenergic agonist presented as an oral tablet for systemic use. It is used to raise blood pressure in patients with orthostatic hypotension and related low‑pressure conditions.

GNH USA supplies Midodrine Tillomed as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Midodrine acts on the peripheral vascular system to treat conditions characterized by low blood pressure.

Orthostatic hypotension: increases standing systolic and diastolic pressure to reduce dizziness and fainting. Neurogenic hypotension: improves vascular tone in autonomic failure. Hypotensive episodes during dialysis: supports hemodynamic stability in patients undergoing renal replacement therapy.

Midodrine may cause a range of adverse reactions, most of which are dose‑related and reversible.

Common Side Effects: - Piloerection (goose‑flesh skin) - Pruritus or skin itching - Urinary retention or difficulty voiding - Supine hypertension (elevated BP while lying down) - Headache or dizziness - Nausea or abdominal discomfort

Serious or Rare Side Effects: - Severe hypertension leading to cardiovascular strain - Bradycardia or arrhythmias - Ischemic events such as myocardial infarction or stroke - Severe allergic reactions (rash, angioedema) - Pulmonary edema in susceptible individuals

Before initiating therapy, clinicians should assess cardiovascular status and monitor blood pressure regularly.

Monitor supine blood pressure: avoid excessive elevation while lying down. Assess renal and hepatic function: dose adjustment may be needed in impairment. Review concomitant antihypertensive agents: risk of excessive pressor effect. Caution in elderly patients: increased susceptibility to supine hypertension. Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Midodrine can interact with several drug classes, altering its pressor effect or causing adverse events.

Major Interactions (Avoid): - Monoamine oxidase inhibitors: risk of hypertensive crisis. - Other alpha‑adrenergic agonists: additive increase in blood pressure.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may blunt compensatory tachycardia. - ACE inhibitors or ARBs: monitor for excessive blood pressure changes. - Diuretics: adjust fluid status to prevent volume depletion. - Anticholinergic agents: increase risk of urinary retention.